IELSG-38: A Phase II Study of Chlorambucil in Combination with Rituximab Followed By Maintenance Therapy with Subcutaneous Rituximab in Patients with Extranodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT)

被引:0
|
作者
Stathis, Anastasios
Gregorini, Anna
Gressin, Remy
Orsucci, Lorella
Perrot, Aurore
Tani, Monica
Coiffier, Bertrand
Musuraca, Gerardo
Guieze, Romain
Marino, Dario
Gini, Guido
Ferrari, Angela
Gyan, Emmanuel
Morschhauser, Franck
Palombi, Francesca
Cavallo, Federica
Le Gouill, Steven
Tilly, Herve
Salvi, Flavia
Conconi, Annarita
Cabras, Maria Giuseppina
Capochiani, Enrico
Califano, Catello
Molinari, Anna Lia
Pulsoni, Alessandro
Ielmini, Nicoletta
Luminari, Stefano
Cavalli, Franco
Zucca, Emanuele
Thieblemont, Catherine
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1506
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type
    Conconi, A
    Martinelli, G
    Thiéblemont, C
    Ferreri, AJM
    Devizzi, L
    Peccatori, F
    Ponzoni, M
    Pedrinis, E
    Dell'Oro, S
    Pruneri, G
    Filipazzi, V
    Dietrich, PY
    Gianni, AM
    Coiffier, B
    Cavalli, F
    Zucca, E
    BLOOD, 2003, 102 (08) : 2741 - 2745
  • [22] RITUXIMAB WITH OR WITHOUT CHLORAMBUCIL FOR THE TREATMENT OF EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA: RESULTS OF A MONOCENTRIC STUDY
    Rigacci, L.
    Kovalchuk, S.
    Mannelli, L.
    Lancia, F.
    Benelli, G.
    Puccini, B.
    Bosi, A.
    HAEMATOLOGICA, 2015, 100 : 464 - 464
  • [23] Absence of efficacy of thalidomide monotherapy in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)
    Troch, M.
    Zielinski, C.
    Raderer, M.
    ANNALS OF ONCOLOGY, 2009, 20 (08) : 1446 - 1447
  • [24] Combination Therapy With Rituximab and Intravenous or Oral Fludarabine in the First-Line, Systemic Treatment of Patients With Extranodal Marginal Zone B-cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type
    Salar, Antonio
    Domingo-Domenech, Eva
    Estany, Cristina
    Canales, Miguel A.
    Gallardo, Fernando
    Servitje, Octavio
    Fraile, Guadalupe
    Montalban, Carlos
    CANCER, 2009, 115 (22) : 5210 - 5217
  • [25] Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine:: A phase II study
    Jäger, G
    Neumeister, P
    Brezinschek, R
    Hinterleitner, T
    Fiebiger, W
    Penz, M
    Neumann, HJ
    Mlineritsch, B
    DeSantis, M
    Quehenberger, F
    Chott, A
    Beham-Schmid, C
    Höfler, G
    Linkesch, W
    Raderer, M
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3872 - 3877
  • [26] Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)
    Barbara Kiesewetter
    Marius E. Mayerhoefer
    Julius Lukas
    Christoph C. Zielinski
    Leonhard Müllauer
    Markus Raderer
    Annals of Hematology, 2014, 93 : 249 - 253
  • [27] Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)
    Kiesewetter, Barbara
    Mayerhoefer, Marius E.
    Lukas, Julius
    Zielinski, Christoph C.
    Muellauer, Leonhard
    Raderer, Markus
    ANNALS OF HEMATOLOGY, 2014, 93 (02) : 249 - 253
  • [28] Extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue of the gallbladder
    Ng, Sally K.
    Epari, Krishna
    Parsons, Sarah
    Wei, Andrew
    Banting, Simon W.
    SURGICAL PRACTICE, 2008, 12 (04) : 137 - 141
  • [29] The Diagnosis of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue
    Huang, Na
    Li, Wei-Min
    CHEST, 2012, 141 (03) : 833 - 833
  • [30] Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in the thymus: Report of four cases
    Shimizu, K
    Ishii, G
    Nagai, K
    Yokose, T
    Ishizawa, K
    Tamaru, J
    Yoshida, J
    Nishimura, M
    Ochiai, A
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (07) : 412 - 416